Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

Data on isoaspartylation of neuronal ELAVL proteins.

Pulido MA, DerHartunian MK, Sehgal P, Laird-Offringa IA.

Data Brief. 2016 Nov 17;9:1052-1055. eCollection 2016 Nov 17.

2.

Isoaspartylation appears to trigger small cell lung cancer-associated autoimmunity against neuronal protein ELAVL4.

Pulido MA, DerHartunian MK, Qin Z, Chung EM, Kang DS, Woodham AW, Tsou JA, Klooster R, Akbari O, Wang L, Kast WM, Liu SV, Verschuuren JJ, Aswad DW, Laird-Offringa IA.

J Neuroimmunol. 2016 Oct 15;299:70-78. doi: 10.1016/j.jneuroim.2016.09.002. Epub 2016 Sep 3.

PMID:
27725125
3.

Zinc(II) Binding Site to the Amyloid-β Peptide: Insights from Spectroscopic Studies with a Wide Series of Modified Peptides.

Alies B, Conte-Daban A, Sayen S, Collin F, Kieffer I, Guillon E, Faller P, Hureau C.

Inorg Chem. 2016 Oct 17;55(20):10499-10509. Epub 2016 Sep 26.

4.

Interplay of histidine residues of the Alzheimer's disease Aβ peptide governs its Zn-induced oligomerization.

Istrate AN, Kozin SA, Zhokhov SS, Mantsyzov AB, Kechko OI, Pastore A, Makarov AA, Polshakov VI.

Sci Rep. 2016 Feb 22;6:21734. doi: 10.1038/srep21734.

5.

Kinetic and structural characterization of amyloid-β peptide hydrolysis by human angiotensin-1-converting enzyme.

Larmuth KM, Masuyer G, Douglas RG, Schwager SL, Acharya KR, Sturrock ED.

FEBS J. 2016 Mar;283(6):1060-76. doi: 10.1111/febs.13647. Epub 2016 Feb 9.

6.

Cu(II)-Zn(II) Cross-Modulation in Amyloid-Beta Peptide Binding: An X-ray Absorption Spectroscopy Study.

De Santis E, Minicozzi V, Proux O, Rossi G, Silva KI, Lawless MJ, Stellato F, Saxena S, Morante S.

J Phys Chem B. 2015 Dec 31;119(52):15813-20. doi: 10.1021/acs.jpcb.5b10264. Epub 2015 Dec 21.

7.

Development and Application of a Nonbonded Cu(2+) Model That Includes the Jahn-Teller Effect.

Liao Q, Kamerlin SC, Strodel B.

J Phys Chem Lett. 2015 Jul 2;6(13):2657-62.

8.

Alzheimer's disease--a panorama glimpse.

Zhao LN, Lu L, Chew LY, Mu Y.

Int J Mol Sci. 2014 Jul 16;15(7):12631-50. doi: 10.3390/ijms150712631. Review.

9.

Activity and architecture of pyroglutamate-modified amyloid-β (AβpE3-42) pores.

Gillman AL, Jang H, Lee J, Ramachandran S, Kagan BL, Nussinov R, Teran Arce F.

J Phys Chem B. 2014 Jul 3;118(26):7335-44. doi: 10.1021/jp5040954. Epub 2014 Jun 24.

10.

Curcumin alters the salt bridge-containing turn region in amyloid β(1-42) aggregates.

Mithu VS, Sarkar B, Bhowmik D, Das AK, Chandrakesan M, Maiti S, Madhu PK.

J Biol Chem. 2014 Apr 18;289(16):11122-31. doi: 10.1074/jbc.M113.519447. Epub 2014 Mar 5.

11.

Disordered amyloidogenic peptides may insert into the membrane and assemble into common cyclic structural motifs.

Jang H, Arce FT, Ramachandran S, Kagan BL, Lal R, Nussinov R.

Chem Soc Rev. 2014 Oct 7;43(19):6750-64. doi: 10.1039/c3cs60459d. Review.

12.

Molecular dynamics study of Zn(aβ) and Zn(aβ)2.

Pan L, Patterson JC.

PLoS One. 2013 Sep 27;8(9):e70681. doi: 10.1371/journal.pone.0070681. eCollection 2013 Sep 27.

13.

Familial Alzheimer's disease Osaka mutant (ΔE22) β-barrels suggest an explanation for the different Aβ1-40/42 preferred conformational states observed by experiment.

Jang H, Arce FT, Ramachandran S, Kagan BL, Lal R, Nussinov R.

J Phys Chem B. 2013 Oct 3;117(39):11518-29. doi: 10.1021/jp405389n. Epub 2013 Sep 13.

14.

Effects of Zn2+ binding on the structural and dynamic properties of amyloid β peptide associated with Alzheimer's disease: Asp1 or Glu11?

Xu L, Wang X, Wang X.

ACS Chem Neurosci. 2013 Nov 20;4(11):1458-68. doi: 10.1021/cn4001445. Epub 2013 Sep 13.

15.

Zn(II) ions substantially perturb Cu(II) ion coordination in amyloid-β at physiological pH.

Silva KI, Saxena S.

J Phys Chem B. 2013 Aug 15;117(32):9386-94. doi: 10.1021/jp406067n. Epub 2013 Jul 31.

16.

Alzheimer's disease: which type of amyloid-preventing drug agents to employ?

Jang H, Connelly L, Arce FT, Ramachandran S, Lal R, Kagan BL, Nussinov R.

Phys Chem Chem Phys. 2013 Jun 21;15(23):8868-77. doi: 10.1039/c3cp00017f. Epub 2013 Feb 28. Review.

17.

Bapineuzumab captures the N-terminus of the Alzheimer's disease amyloid-beta peptide in a helical conformation.

Miles LA, Crespi GA, Doughty L, Parker MW.

Sci Rep. 2013;3:1302. doi: 10.1038/srep01302.

18.
19.

Structures and free energy landscapes of aqueous zinc(II)-bound amyloid-β(1-40) and zinc(II)-bound amyloid-β(1-42) with dynamics.

Wise-Scira O, Xu L, Perry G, Coskuner O.

J Biol Inorg Chem. 2012 Aug;17(6):927-38. doi: 10.1007/s00775-012-0909-9. Epub 2012 Jun 7.

20.

All-d-Enantiomer of β-Amyloid Peptide Forms Ion Channels in Lipid Bilayers.

Capone R, Jang H, Kotler SA, Connelly L, Teran Arce F, Ramachandran S, Kagan BL, Nussinov R, Lal R.

J Chem Theory Comput. 2012 Mar 13;8(3):1143-1152. Epub 2012 Feb 3.

Supplemental Content

Support Center